Cove Private Wealth’s Boston Scientific BSX Stock Holding History

Cove Private Wealth’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,750	Closed	-$235K	–	208
2026 Q1	$235K	Hold	3,750	–	–	0.05%	172
2025 Q4	$358K	Hold	3,750	–	–	0.11%	126
2025 Q3	$366K	Hold	3,750	–	–	0.12%	120
2025 Q2	$403K	Buy	3,750 +1,750	+88%	+$177K	0.14%	114
2025 Q1	$202K	Buy	+2,000	New	+$201K	0.11%	121

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Cove Private Wealth's BSX Position: Q2 2026 in Review

Cove Private Wealth sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,750 shares — an estimated $235K sold.

Cove Private Wealth first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $403K in Q2 2025. 529 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cove Private Wealth reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Cove Private Wealth sold 3,750 Boston Scientific shares in Q2 2026, an estimated $235K.
Cove Private Wealth first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
Cove Private Wealth's Boston Scientific position peaked at $403K in Q2 2025.
529 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.